Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes the U.K. DAFNE experience

Diabetes Care

Volumn 35, Issue 8, 2012, Pages 1638-1642

  Hopkins, David ^a   Lawrence, I A N ^b   Mansell, Peter ^c   Thompson, Gillian ^d   Amiel, Stephanie ^e   Campbell, Michael ^f   Heller, Simon ^g  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIABETES EDUCATION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DISTRESS SYNDROME; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PROBLEM AREAS IN DIABETES SCORE; PSYCHOLOGICAL WELL BEING; RETROSPECTIVE STUDY; SCORING SYSTEM; SELF REPORT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

ADULT; ANXIETY; DEPRESSION; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84864380622     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1579     Document Type: Article

References (18)

1. Mühlhauser I, Jörgens V, Berger M, et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983;25:470-476 (Pubitemid 14200881)
2. Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 1995;18:625-630
3. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746-749
4. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208
5. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370 (Pubitemid 13098606)
6. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995;18:754-760
7. Campbell MJ, Machin D, Walters SJ. Common pitfalls. In Medical Statistics: A Textbook for the Health Sciences. 4th ed. West Sussex, U.K., Wiley, 2007, p. 278-296
8. Bott S, Bott U, Berger M, Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997;40:926-932 (Pubitemid 27316573)
9. Sämann A, Mühlhauser I, Bender R, Kloos Ch, Müller UA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 2005;48:1965-1970 (Pubitemid 41416904)
10. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994;344:283-287 (Pubitemid 24230294)
11. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-1689 (Pubitemid 23318128)
12. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994;43:1426-1434
13. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006;49:469-477 (Pubitemid 43277869)
14. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001;357:7-8 (Pubitemid 32056492)
15. Bjelland I, Dahl AA, Haug TT, Necklemann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52:69-77 (Pubitemid 34192886)
16. Shaban MC, Fosbury J, Kerr D, Cavan DA. The prevalence of depression and anxiety in adults with type 1 diabetes. Diabet Med 2006;23:1381-1384 (Pubitemid 44787805)
17. Lloyd CE, Dyer PH, Barnett AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med 2000;17:198-202 (Pubitemid 30212291)
18. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the Problem Areas In Diabetes scale. Diabetes Care 2000;23:1305-1309